H.R.3391 — Gabriella Miller Kids First Research Act 2.0
House Roll Call
H.R.3391
| Bill | H.R.3391 — Gabriella Miller Kids First Research Act 2.0 |
|---|---|
| Vote question | On Motion to Suspend the Rules and Pass, as Amended |
| Vote type | 2/3 Yea-And-Nay |
| Result | Passed |
| Totals | Yea 384 / Nay 4 / Present 0 / Not Voting 44 |
| Party | Yea | Nay | Present | Not Voting |
|---|---|---|---|---|
| R | 192 | 4 | 0 | 23 |
| D | 192 | 0 | 0 | 21 |
| I | 0 | 0 | 0 | 0 |
Research Brief
On Motion to Suspend the Rules and Pass, as Amended
Bill Analysis
The Gabriella Miller Kids First Research Act 2.0 (HR 3391) aims to enhance research funding for pediatric diseases and conditions, building on the original Gabriella Miller Kids First Research Act. This legislation establishes a dedicated funding stream for pediatric research through the reallocation of existing funds from the National Institutes of Health (NIH) and the Centers for Disease Control and Prevention (CDC).
Key Provisions:
- The bill authorizes the transfer of $50 million annually from the NIH’s existing budget to the newly created “Gabriella Miller Kids First Research Fund.” This fund is specifically designated for research related to pediatric cancers and other serious childhood diseases.
- The legislation mandates that the NIH prioritize funding for innovative research proposals that focus on conditions affecting children, thereby addressing the critical need for more effective treatments and interventions.
Agencies Affected:
- The NIH and CDC are the primary agencies involved, with the NIH responsible for administering the funds and overseeing the research projects funded through the Gabriella Miller Kids First Research Fund.
Beneficiaries:
- The primary beneficiaries of this legislation are children suffering from serious health conditions, their families, and the broader pediatric healthcare community. Additionally, researchers and institutions engaged in pediatric health research will gain access to increased funding opportunities.
Key Timelines:
- The bill was introduced in the House of Representatives and successfully passed through both chambers of Congress before being signed into law, becoming Public Law No: 118-228. The law is effective immediately, allowing for the prompt allocation of funds to support pediatric research initiatives.
Overall, the Gabriella Miller Kids First Research Act 2.0 represents a significant commitment to advancing pediatric health research, ensuring that children’s health issues receive the attention and resources necessary for progress in treatment and care.
Yea (384)
K
Kelly Armstrong
E
Earl Blumenauer
J
Jamaal Bowman
K
Ken Buck
L
Larry Bucshon
M
Michael Burgess
C
Cori Bush
K
Ken Calvert
Y
Yadira Caraveo
T
Tony Cárdenas
M
Matt Cartwright
L
Lori Chavez-DeRemer
G
Gerald Connolly
J
Jason Crow
A
Anthony D'Esposito
L
Lloyd Doggett
J
John Duarte
J
Jeff Duncan
A
Anna Eshoo
A
A. Ferguson
S
Scott Franklin
M
Matt Gaetz
M
Mike Gallagher
R
Ruben Gallego
J
John Garamendi
M
Mike Garcia
B
Bob Good
K
Kay Granger
G
Garret Graves
M
Mark Green
J
Jeff Jackson
D
Daniel Kildee
D
Derek Kilmer
A
Ann Kuster
J
Jake LaTurner
D
Debbie Lesko
B
Blaine Luetkemeyer
K
Kathy Manning
L
Lucy McBath
L
Lisa McClain
P
Patrick McHenry
M
Marcus Molinaro
G
Grace Napolitano
W
Wiley Nickel
B
Bill Pascrell
D
Donald Payne
M
Mary Peltola
G
Greg Pence
B
Bill Posey
C
Cathy Rodgers
M
Matthew Rosendale
C
C. Ruppersberger
J
John Rutherford
J
John Sarbanes
D
David Schweikert
P
Pete Sessions
A
Abigail Spanberger
M
Michelle Steel
R
Rashida Tlaib
N
Nydia Velázquez
M
Michael Waltz
D
Debbie Wasserman Schultz
B
Brad Wenstrup
J
Jennifer Wexton
S
Susan Wild
B
Brandon Williams
Not Voting (44)
C
Colin Allred
D
Dan Bishop
J
Jerry Carl
R
Raúl Grijalva
S
Sheila Jackson Lee
D
Doug Lamborn
B
Barbara Lee
A
Alexander Mooney
D
Dean Phillips
K
Katie Porter
E
Eric Swalwell
D
David Trone
